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SCIENTIFIC PART
PART I. STUDIES ON LYMPHOCYTE
A. Electrophoretic Mobility of Fractionated Peripheral Lymphocytes
from Normal Adults, Hemodialysis Patients and Kidney Transplant
Recipients.
Introduction
B lymphocyte is one of the major subpopulations of lymphocytes, and
this cell, as a precursor of plasma cell, does play a pivotal role in an
organ transplantation either to reject the graft by production of cytotoxic
antibodies or adapt the graft by production of enhancing antibodies. Despite
this, B lymphocyte has received less attention than other lymphocyte sub-
populations from the transplantation immunologists, probably because of limited
biological means to study immunobiological function of B lymphocytes.
To evaluate the potential of lymphocyte electrophoresis in predicting
the outcome of kidney transplants and as a method for separation of lymphocyte
subpopulations, we studied electrophoretic mobilities (EPM) of peripheral
lymphocytes, fractionated (T and non-T lymphocytes) and nonfractionated,
from normal subjects, chronic hemodialysis patients and kidney transplant
recipients previously.	 The conclusions resulting from the previous study were:
1) EPM of non-T lymphocytes from chronic maintenance hemodialysis patients
and kidney transplant recipients is significantly decreased from normal, and
transplant recipients exhibit the greatest change, and 2) a series of
experiments suggest that decreased EPM of non-T lymphocytes in kidney trans-
plant recipients is due to actual alterations in proportions of subsets of
non-T lymphocytes and/or alterations in functional status of existing non-T
lymphocyte subsets as a response to either kidney transplantation per se or immuno-
suppressive therapy. Since the lymphocytes which do not form spontaneous
rosette formation with sheep erythrocytes, referred to as "non-T lymphocytes"
in that study are heterogenous with regard to cell type (B lymphocytes, null
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cells and possibly other cell types), the observation of decreased EPM of
non-T lymphocytes from hemodialysis patients and kidney transplant recipients
is actually a net result of the combined EPM of B lymphocytes and null calls.
Thus, the results raised new questions: which subpopulation of the non-T
lymphcoytes is primarily affected and is shown a decreased EPM in chronic
hemodialysis patients and kidney trans plant recipients? Are they B
lymphocytes or null cells, or both?
We developed a technique to separate B lymphocytes and null cells from
non-T lymphocyte preparation to answer these questions and conducted a
series of new experiments studying EPM of T, B and null cells from normal
subjects (N - 5), chronic hemodialysis patients (N - 5) and kidney transplant
recipients (N w 11).
Materials and Methods
Materials
EPM of T, B lymphocytes and null cells were studied fram 5 normal adult
subjects, 5 patients receiving chronic maintenance hemodialysis and 11 kidney
transplant recipients. Criteria for selection of study subjects are identical
with those which were used for the previous study (Phase I and Phase II). All
subjects were fully informed of the study and the patients who participated
in this study were treated exactly the same as the patients who did •got
participate in the study.
Normal subjects' ages ranged from 24 to 40 years, and all were females
except one. The uremic subjects' ages ranged from 40 to 64 years; 3 weze
males and all had been on hemodialysis treatment for at least one year prior
to the study. Ages of the kidney transplant recipients ranged from 20 to 57
years and 9 were males. Seven of these patients received renal allografts 3
to 26 days prior to this experiment (Short-term Study), and were on immuno-
suppressive therapy consisting of 50 to 200 mg of prednisone and 100 to 200 mg
of azathioprine per day. The remaining 4 kidney transplant recipients
received renal allografts 6 months to 5 years prior to this experiment (Long-
term Study), and were also on immunosuppressive drugs, but were receiving
lower doses (prednisone 10 to 20 mg and azathioprine 100 mg per day). Although
^ Y—
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all of the patients in the Long-term Study group had good and stable graft
function, 2 of the 7 patients in the Short-term Study group had no significant
graft function at the time of the study and 2 of these patients subsequently
lost their grafts due to irreversible graft rejection.
Method
Separation of lymphocytes.
50 to 80 ml of freshly drawn venous blood was mixed with preservative-free
heparin, layered on a Ficoll-Hypaque gradient, and lymphocytes were separated
after centrifugation. To remove monocytes and neutrophilic leucocyte., the
lymphocyte preparation was suspended ?n Hank's Balanced Salt Solution (HBSS)
with 10% heat inactivated (decomplemented) human AB serum and incubated on
Falcon plastic petri dishes for 1 hour at 37°C in 5% CO 2
 - 95% 02 . This
procedure usually provides over 90% pure and over 90% viable lymphocytes. (The
details of this procedure were described in the previous report.)
Separation of T lymphocytes (E rosetting).
Sheep erythrocytes (SRBC) were washed twice in HBSS, and three drops of
packed SRBC were suspended in 10 ml HBSS. Equal volumes of human lymphocytes
(2 x 10 6
 lymphocytes/ml RFMI 1640 + 10% AB serum + 1% glutamine) and SRBC
suspension were combined in Falcon plastic tubes, and the tubes were centrifugated
at 500 rpm for 5 minutes at 25°C. The calls were incubated overnight (18 hours)
at 4°C. The following day, the pellets were gently resuspended and were layered
over 12 ml Ficoll-Hypaque and centrifugated at 1,400 rpm for 40 minutes at 4°C.
Unrosetted lymphocytes were removed from the interface. Rosetted T lymphocytes
in the pellet beneath the Ficoll-Hypaque were washed with ammonium chloride
tris buffer to lyse SRBC and washed again with HBSS + 10% AB serum.
Separation of B lymphocytes and null cells (E.A.C. rosetting.)
The lymphocyte preparation which did not form rosettes with SRBC is
referred to as "non-T lymphocytes preparation" and contains predominantly B
lymphocytes, as well as null cells and a few monocytes. The "non-T lymphocyte
preparation" was further processed to separate primarily B lymphocytes from
null cells.
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SRBC were washed twice in Dulbecco's PBS (Grand Island Biological Co.,
Grand Island, N.Y.) prior to the incubation with rabbit anti-SRBC antibody
(Cappel Laboratories, Inc., Downingtown, Pa.). Equal volumes of a 5% SRBC
solution and a 1/1000 dilution of the antibody were combined and incubated
for 30 minutes at 37°C. Following the incubation, the SRBC-antibody (E.A.)
was washed twice in HBSS. The E.A. complex was resuspended in a 5%
solution and combined in equal volumes with a 1/20 dilution of fresh human
serum, and the mixture was incubated for 30 minutes at 37°C followed by two
washes with HBSS. The SRBC-antibody complement (E.A.C.) was resuspended in
1% solution with HESS. Equal volumes of the E.A.C. suspension and the "non-T
Lymphocyte preparation" (4 x 10 6
 cells/ml in RPMI 1640 and 10% FCS) were
incubated at 37°C for 30 minutes following a centrifugation at 1000 rpm for
5 minutes.
After incubation, the pellet was resuspended by hard mixing and layered
over Ficoll-Hypaque. Prior to layering, ratio of 100 cells with and without
rosettes was counted. The layered suspension was centrifugated for 15 minutes
at 20°C 1000 rpm. The non-rosetted cells, designated as null cells were
removed from the interface and washed twice with HBSS. The rosetted B
lymphocytes from a pellet were treated with ammonium chloride Tris buffer
to lyse the SRBC and washed twice with Ca and Mg free HBSS and 10% FCS.
Electrophoresis.
Electrophoretic mobility of lymphocytes was determined using Cylindrical
Microelectrophoresis Apparatus (Type U2, Rank Brothers, Bottisham, Cambridge,
England) with suspension media of 0.03 mol. liter
-1
 ionic strength,
4.0 gm/dl sorbitol, buffered to pH 7.4 ± 0.2 with sodium bicarbonate, at 25°C.
Fresh human erythrocytes were used as a reference material before and after
each measurement of lymphocyte electrophoretic mobility. Each one hundred of
T, B and null cells were studied in each subject.
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Results
Ranges and means (*-SEM) of EPM of T, B and null cells from normal
subjects, chronic hemodialysis patients and kidney transplant recipients
are shown in Table 1. Also, frequency polygons of EPM produced from the
results are displayed in Figures 1 to 6 to compare the differences between
groups of study subjects in the same lymphocyte subpopulation and between
lymphocyte subpopulations in the same group of study subjects.
In normal subjects, T lymphocytes exhibited highest EPM and null cells
exhibited lowest RPM, and the difference of EPM between null cells from T
(P< 0.03) were statistically significant. In chronic hemodialysis patients,
EPM of both of the I (P <0.03) and B lymphocytes (P <0.01) were significantly
decreased from EPM of respective lymphocytes from normal subjects, and EPM of
B lymphocytes was so low that EPM of B and null cells were identical. In
kidney transplant recipients, EPM of T (P < 0.003)and B lymphocytes (P< 0.01)
were again significantly lower than those of normals, and 3 lymphocyte EPM
approached to null cell EPM. However, there was no difference in EPM of all
subpopulations of lymphocytes between short and long-term post-transplant
patients, and between hemodialysis patients and kidney transplant recipients.
EPM of null cells was identical among the normal subjects, hemodialysis
patients and kidney transplant recipients.
Comments
In the previous report, we had shown that th q EPM of non-T lymphocytes in
hemodialysis patients and kidney transplant recipients, is significantly
decreased than that of normal subjects, and that the transplant recipients
exhibited the greatest changes. The low EPM in transplant recipients,
however, was poorly correlated with either duration of transplantation,
doses of immunosuppressive drugs, presence or absence of rejection episode,
or eventual outcome of the graft. 	 In addition, a series of in vitro experi-
ments disclosed that the alteration in EPM of lymphocytes in the transplant
recipients is neither reversible nor caused by humoral factors, immunological
or pharmacological, presented in the recipients' sera. Thus, we concluded
that decreased EPM of non-T lymphocytes in kidney transplant recipients
_'.s due to actual alterations in proportions of subsets of non-T lymphocytes
and/or alterations in functional status of existing non-T lymphocyte subsets
as a response to kidney transplantation.
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In the present study, our effort was concentrated on identifying the
subpopulation(s) of lymphocytes which is primarily affected and is shown
decreased EPM in these patients. The results of the study delineate that
there are distinct differences of EPM among three major subpopulation of
normal human peripheral lymphocytes. Furthermore, in dialysis patients and
transplant recipients, EPM of both T and B lymphocytes are significantly
reduced, while EPM of null cells is unchanged, as compared to EPM of
respective subpopulations of lymphocytes in normal subjects. In this study,
again, the low EPM of B lymphocytes has been shown uniformly in transplant
recipients, regardless of duration and outcome of transplant, doses of
immunusuppressive drugs, presence or absence of rejection episode, and
degree of graft function.
Unlike the previous study, however, EPM of T-lymphocytes in both
hemodialysis patients and transplant recipients, was also significantly
reduced from that of normal subjects, but there was no difference in EPM
of T-lymphocytes between hemodialysis patients and transplant recipients.
The present study generally supports our previous contention that
reduced EPM of peripheral lymphocytes in transplant recipients is a non-
specific phenomenon, as discussed in the previous report in detail.
Furthermore, measurement of EPM of peripheral lymphocytes from these patients
seems to have neither diagnostic (rejection vs. adaptation) nor prognostic
(eventual fate of the graft) implications.
As shown in Figures 1-6, although there are considerable differences
in mean EPM of lymphocytes between different subpopulations of lymphocytes
and different groups of study subjects, major portions of EPM histograms
are so closely superimposed, it appears unlikely that one subpopulation of
lymphocytes can be completely separated from another by means of lymphocyte
electrophoresis alone, even when preparatory electrophoresis is readily
available. However, it is possible that if the net electrical charge of a
subpopulation of lymphocytes is modified by chemical or immunological
treatment, that subpopulation can be separated from the others. Such
treatments, both immunological and chemical, can be explored and optimized
by further research in lymphocyte surface receptors,
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Conclusions
Electrophoretic mobility of peripheral T and B lymphocytes and null
cells was determined from normal adults, hemodialysis patients and kidney
transplant recipients by using a Cylindrical Microelectrophoresis Apparatus,
and the following conclusions have been drawn from this study:
1. Each subpopulation of peripheral lymphocytes has distinct EPM,
and T lymphocyte has the highest mobility, while null cell has
the lowest mobility.
2. Mean EPM of both T and B lymphocytes from hemodialysis patients
and transplant recipients is significantly lower than that of
normals.
3. EPM of null cells is identical between normal subjects, hemodialysis
patients and transplant recipients.
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B. Preparatory Electrophoresis of Human Peripheral Lymphocytes.
To Explore the potentiality of lymphocyte electrophoresis as a means
for separation of lymphocyte subpopulations, preparatory electrophoresis
of peripheral human lymphocytes was attempted three times with collaboration
of Dr. Richard N. Griffin, Space Sciences and Laboratory, General Electric
Company, Valley Forge, PA.
The lymphocytes from peripheral blood were prepared as described
previously (total approximately 6 X 10  cells with over 85% viability by
dye exclusion test).
The following morning, the lymphocytes suspended in Hank's balanced
salt solution were brought to Space Sciences and Laboratory of General
Electric Co., Valley Forge, in an ice box. When the lymphocytes were suspended
in electrophoretic media (phosphate buffered Hanning's solution) for electro-
phoresis, however, the lymphocytes started to clump together within 15-20
minutes. Thus, a large portion of the cells were lost during this procedure.
After the clumps were removed, the cells were resuspended in a new electro-
phoretic medium (0.01 N NaCl with 4.9% 3orbitol (300 mOsmol) at pH 7.2], and
were electrophoresed at a rate of 0.8 ml/hr, with Backman's continuous flow
electrophoretic device. Fractionated lymphocytes were collected in 30 tubes
according to order of electrophoretic mobilities of lymphocytes. At the
end of the procedure, electrophoretic medium was removed from the tubes by
centrifuge, and the fractionated lymphocytes were resuspended with Hank's
balanced salt solution and brought back to New York.
The next day, a cell count and viab^lity test were performed and the
results were as follows:
i. The total number of lymphocytes recovered after electrophoretic
fractionation was 6.24 X 10 , which approximates 1/1000 of the
original lymphocytes we had prepared.
ii. Approximately 95% of the lymphocytes were recovered from the
tubes between No. 10 - 15, out of the total 30 collection tubes
(Figure 7).
iii. Viability of the lymphocytes fractionated in the tubes varied
from 32% to 72%.
Although the extremely low recovery rate of the lymphocytes might have
been due to lymphocyte clumping prior to electrophoresis, both efficiency of
fractionation and viability of fractionated lymphocytes in this experiment
were also relatively poor.
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Since this experiment was only a pilot study and was not conducted
, order optimum conditions, we attempted two more such experiments. At this
time, transportation of lymphocyte specimens between New York and Valley
Forge was made by special delivery via air mail. On both occasions, however,
the fractionated specimens did not arrive in New York in time and all
lymphocytes were disintegrated during the transportation ;,eriod. Unfortunately,
due to the schism of essential facilities in New York and Valley Forge, these
and future experiments cannot be conducted successfully.
6.	
...	 W.	 --	 _.. -,...,..
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C. Electrophoretic Mobil sy of Peripheral Lymphocytes Treated with
Immunoglobulin
Since the results of the previous and present studies indicate that
it appears unlikely that subpopulations of lymphocytes can be separated by
means of the electrophoretic technique alone, we attempted to alter the electro-
chemical property of the lymphocyte surface by antihuman IgG antibody (immuno-
globulin) treatment. We hoped to see that modification of the surface electrical
charge of onr- subpopulation, for example B lymphocytes in this experiment, by
such immunologic treatment would augment the difference of the electrophoretic
property of that subpopulation from others, so that the treated subpop,ilation
can be electrophoretically separated from the non-treated subpopulation, or
vise versa.
Materials and Method
Peripheral lymphocytes from three normal subjects were prepared to enrich
T and B lymphocytes as described previously (E rosetting technique for T
lymphocyte preparatio" and EAC rosetting technique for B lymphocyte preparation).
Both lymphocyte preparations were suspended in phosphate buffered saline con-
taining either 10% fetal calf serum (Cont of Group) or rabbit's antihuman
IgG antibody (human r chain specificl at a final concentration of 2.5 X 106
lymphocytes per ml. and 1.25 mg/ml rabbit's IgG (Experimental Group), and
were incubated at 4°C for 18 hours. The following day, the treated cell
preparations were washed twice with electrophoretic suspending media, and
resuspended in electrophoretic suspending media to desired concentration.
Chemical composition of the media, the electrophoretic apparatus and the
procedure of electrophoresis used in this experiment were described in detail
in previous reports.
Results
One uniform finding in this experiment was that both T and B lymphocytes
treated with rabbit's antihuman IgG antibody tended to clump together, while
the lymphocytes incubated with fetal calf serum remained in s-ospension.
Major portions of the reacted lymphocytes were, thus, probably lost when the
clumps were removed from phosphate buffered saline prier to electrophoresis.
Therefore, we were able to study EPM of treated lymphocytes from the small
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number of those lymphocytes (20 to 30 lymphocytes per case) which did not
form clumps but remained in suspension.
The results of EPM of these lymphocytes are shown in Table Z.
Comments and Conclusion
Since we lost a large portion of those lymphocytes, which apparently
responded to the rabbit's antihuman IgG antibody treatment, in the Experimental
Group, observed EPM of lymphocytes from that group unlikely represent true EPM
of the treated lymphocytes. Thus, the present study failed to provide data
on the EPM of lymphocytes treated with antihuman IgG antibody. To obtain such
information, it is prerequisite that any treatment to modify electrochemical
characteristics of the lymphocyte surface should not associate with clumping
of the reactive lymphocytes.
Although we have not studied this possibility, we suspect that use of
F ab portion only, instead of the entire molecules, of rabbit's antihuman
IgG antibody, may alter the lymphocyte surface property without induction of
clumping problems. Another possibility is that a shorn reaction period, such
as 1 to 4 hours_ incubation of lymphocytes with immunoglobulin,'-may prevent
lymphocyte aggregation or clumping, and it is worth trying in the future.
z
I
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Legend to Figures
Figure 1. Electrophoretic Mobility of Lymphocytes in Normal Subjects
Figure 2. Electrophoretic Mobility of Lymphocytes in Hemodialysis Patients
Figure 3. Electrophoretic Mobility of Lymphocytes in Transplant Recipients
Figure 4 Electrophoretic Mobility of T Lymphocytes
Figure 5. Electrophoretic Mobility of B Lymphocytes
Figure 6. Electrophoretic Mobility of Null Cells
	
1
i
Figure 7. Fractionation of Peripheral Lymphocytes by Beckman's Continuous
	 1
Flow Electrophoresis
Legend to Table
'F	 Table 1. Electrophoretic Mobility of Fractionated Peripheral Lymphocytes
j
	
	 from Normal Adults, Hemodialysis Patients- and Kidney Transplant
Recipients
Table 2. Electrophoretic Mobility of T and B Lymphocytes Treated with
Rabbit's Antihuman IgG Antibody
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PART II. STUDIES ON LYMPHOCYTE ACTIVATION
Our studies on lymphocyte cell-surface phenomenon have been
continued through an examination of the effect of microtubular
disruption on lymphocyte activation induced by cell to cell
contact.
Drugs that disrupt microtubular assemblies inhibit various aspects of
mitogen- and antigen- induced lymphocyte activation )-3 . The microtubular
apparatus modulates cell shape and surface architecture 4-5 and has also been
implicated in mediating stimulatory signals from the plasma membrane to
intracellular ,aites 1 . Thus, disruption of microtubules could affect lymphocyte
activation by two distinct mechanisms: (1) by affecting surface interactions
between membrane sites and stimulatory agents (i.e., mitogens, antigens, and
allogenic cells); and (2) by interfering with propagation of stimulatory
signals. Colchicine, a drug that binds to and disrupts microtubules, inhibits
mitogen-induced 3H-thymidine ( 3H-TdR) incorporation)-3 , but has no effect on
some of the early changes associated with lymphocyte activation 2 . A recent
report noted that the stimulation of neuraminidase-treated lymphocytes by
galactose oxidase is not inhibited by colchicine at concentrations that
inhibit the mitogenic response induced by concanavalin A (Con A) 6 . We report
here that colchicine potentiates the mitogenic effect of sodium perodate (I04),
a mitogen that requires cell-cell interaction to induce blastogenesis
7-8
.
This potentiation is obtained by brief incubation of cells with colchicine
followed by washing to remove excess reagent. Under these experimental
conditions, the mitogenic effect of Con A is inhibited.
Figure lA and 1B illustrate the effect of pretreating cells with varying
concentration of colchicine on 3H-TdR incorporation induced by I04 and Con A.
Under these conditions, the response to I04 is progressively enhanced up to
a colchicine concentration of 10-6 M, and then returns to baseline levels
as the colchicine concentration is further increased to 10 -4 M. The response
to Con A, on the other hand, is progressively inhibited by colchicine at
10 7 to 10-5 M. 3H-Uridine and 3H-leuciae incorporation were also used to
quantitate the stimulatory effect of I04 and Con A using the experimental
conditions outlined in Figure 1. Incorporation of these precursors gave
similar results to those for 3H-TdR incorporation. When colchicine was
allowed to remain in the cultures (Figure 1C), there was a decrease in 3H-TdR
incorporation by cells stimulated with either 104 or Con A.
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The potentiation of the mitogenic effect of I04 by colchicine was.found
both when the cells were pretreated with colchicine followed b y 10 and when
the cells were first treated with I04 followed by a 30 mi.n ineubatign with
colchicine (Figure 2). It was noted that cells pra'acubated for 30 'min with
or without colchicine respond maximally at lower concentrations of IQ4:than
do non-preincubated calla (Figu.-e 2). Nevertheless, the colchicine-;siduced
enhancement of the response is seen at all I04 concentrations tested. These
experiments indicated that the enhcncing effect of colchicine is not related
to exposure of target sites for I04 action.
Lumicolchicine, a photo-inactivated derivative of colchicine, was
compared with colchicine for its effect on the mitogenic response to I04 and
Con A. Lumicolchicine does not bind nor disrupt microtubules, but shall-.s
some other, nonspecific, properties with colchicine 9 . Figure 3 illustrates
a typical experiment. Enhancement of I04 and inhibition of Con A responses
by colchicine are again noted, but lumicolchicine had little or no effect.
These data indicate that the effects of colchicine, seen un er our experimental
conditions, are related to colchicine binding and disruption of microtubules.
The extent of residual colchicine bound to cells was assayed by deter-
mining the amount of 3H-colchicine bound to extracts (100,000 g X 45 min
supernatant) 10
 of cells pretreated with unlabelled colchicine (10 -6
 M) for
30 min. 1.03p moles/mg protein 3H-colchicine was bound to extracts of cells
preincubated without colchicine, and binding decreased to 0.73 a moles/mg
protein following preincubation with colchicine.
I04
 activates lymphocytes by generating aldehyde moieties on terminal
sialyl residues on the cell surface ll . I04 modified cells can undergo
blastogenesis in the presence of macrophages, and unmodified cells can be
stimulated by I04 - treated irradiated macrophages or by I04 - treated
lymphocytes in the presence of macrophages ?-a . We therefore determined the
effect of colchicine on cultures where I04 - treated and irradiated cells are
used to stimulate cells that are not treated with I04. The results (Figure 4)
show that enhanced proliferation occurred only when 104 - modified cells
(used either as stimulatory or responding cells) were treated with colchicine.
The extent of colchicine enhancement of the response of cells treated directly
with I04 was greater than that seen by treating I04 - modified and irradiated
cells with colchicine and using them to stimulate untreated cells. These
findings suggest that the major effect of colchicine is on I04 - modified
responding cells.
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Blastogenesis induced by I04 requires macrophages for maximal effect 12
Untreated macrophages reconstitute the response of purified T cells to I04
and also reconstitute the enhanced response of colchicine-treated purified
T cells to I04. Thus macrophages are not the target for colchicine action.
These data suggest that colchicine enhances I04 - induced blastogenesis
by disrupting microtubules, altering cell-surface architecture, and facil-
itating cell-cell interactions. The inhibitory effect of colchicine on
later events in blastogenesis was probably eliminated in our experiments by
the brief exposure of cells to colchicine. Preliminary data from our
laboratory indicate that colchicine also potentiates proliferation in mixed
lymphocyte culture when either stimulating or responding cells are pretreated
with the reagent.
Several investigators have reported that cytochalasin B, a drug that
interacts with microfilaments, enhances lymphocyte stimulation in response
to Con A and phytohemagglutinin as well as to I04, but does not enhance
the response to antigens 13-14	In contrast to these effects of cytochalasin B,
our studies indicate that brief pretreatment with colchicine enhances
lymphocyte responses to I04 and to allogenic cells, but not to Con A. These
findings suggest that colchicine has a selective effect on lymphocyte
proliferation induced by cell-cell interaction. Agents that influence the
integrity of the microtubular assembly may therefore modulate the initiation
of immune responses {n,olving cell to cell contact.
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FIGURE LEGENDS
Fig. 1 Effect of colchicine on 3H-TdR incorporation in lymphocytes
stimulated by I04 and Con A. Human peripheral lymphocytes were obtained
from healthy normal subjects, age 21 - 45, by Ficoll-Hypaque gradient
centrifugation 15 . Cells (107
 /ml) suspended in phosphate buffered saline
(PBS) were treated with colchicine (Sigma), at concentrations specified in
the figure, for 30 min at 37° and washed X 2 in PBS. Aliquots were then
treated with I04
 (107 cells/ml in PBS were incubated with 2mM Na:0 4 for 30 min
at 0° and washed X 2) and suspended (10 6
 ce:1/ml) in RPMI 1640, containing
5% heat-inactivated fetal calf serum, and incubated (0.2 ml aliquots) in
flat-bottom microwells (Microtest II, 'Falcon 3040) at 37° in a 952 air - 5%
CO2 incubator for 72 hrsll . Additional samples were cultured with or without
Con A (2 pg/ml). Cultures were pulsed with 2 u Ci 3H-TdR for the last 20 hr
of culture and incorporation into DNA measured 12 . Panel A indicates the
relative change in 3H-TdR incorporation (percent incorporation of colchicine-
free cultures) of I04 (e) and Con A ( o ) treated cells after 30 min exposure
to colchicine at different concentrations. Points indicate mean t SEM of
results obtained using 6 - 12 different individuals' cells. Panes B indicates
the actual change in 3H-TdR incorporation (cpm) that results from colchicine
treatment of I0 4 - stimulated cells. 3H-TdR incorporation into cells stimulated
with Con A without preincubation with colchicine was 165-*23 cpm X 10 -3 . Panel
C shows a typical experiment on the effect of culturing cells with colchicine
present throughout the incubation period (I04 - treated cells [• ]; Con A -
treated cells [o ] ) .
Fig. 2 Colchicine effect I04 - induced lymphocyte proliferation: effect
of sequence of treatment. Cells were either pretreated with colchicine
followed by I04 (Panel A) or with I0 followed by colchicine (Panel B).
o - cells exposed to colchicine (10 M); • = control cells.
Fig. 3 Lumicolchicine effect on I04 and Con A induced lymphocyte proliferation.
Cells were preincubated with either colchicine or lumicolchicine at various
concentrations as described in Figure 1 and stimulated with I04 or Con A.
Lumicolchicir.^ was prepared as previously described 9 . • = I04 stimulation of
colchicine-treated cells; o = I04 stimulation of lumicolchicine-treated cells;
a- Con A stimulation of colchicine-treated cells; and Ci = Con A stimulation of
lumicolchicine-treated cells.
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Fig. 4 Enhancement of I04 - induced lymphocyte proliferation when either
responding or stimulating cells are preincubated with colchicine. Irradiated
cells (3,000 R, Cesium source) (S) were treated with 104 (S IO4 ) and colchicine
(ScI04) and used to stimulate nonirradiated cells, with (R c ) and without (R)
colchicine pretreatment. Lymphocytes were also treated directly with 104 (L104)
and colchicine (Lc104). Results are expressed as mean * SEM (n = 3 individuals'
cells) of the percent stimulation of control cells that had not been exposed
to colchicine. 3R-TdR incorporation in the control cultures was L 104 u 40.6
4.1 cpm X 10 3; S 104 R - 21.1 ± 8.2'cpm X 10 3
7
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SUMMARY AND SUGGESTIONS FOR FUTURE RESEARCH
These studies have been devoted to an examination of the separation
of human peripheral lymphocytes by electrophoresis. A microelectrophoretic
technique was utilized to determine the feasibility and properties of this
type of separatory procedure with a view toward possible utilization of
of preparative lymphocyte electrophoresis at 0 G. The ultimate goals of
this research were to separate subgroups of lymphocytes and study their
properties with a view toward the eventual use of these subfractions in
clinical medicine. Multiple studies utilizing microelectrophoresis have
been carried out in both normal individuals and those receiving renal
transplants. The transplant recipient group was chosen because they had a
well-defined antigenic stimulus. Histograms of the electrophoretic
mobility of human lymphocytes and lymphocyte subpopulations were analyzed
by a variety of statistical methods. The major findings were that human
T and B cell lymphocyte subpopulations had a slight difference in electro-
phoretic mobility; the group of transplant recipients had more polydisperse
histograms than the normal group and, when isolated subpopulations were
studied separately, it was found that the B cell subpopulations of the
transplant recipients had a significantly altered electrophoretic mobility.
These studies suggest a change in lymphocyte subpopulations following a
profound antigenic stimulus and immunosuppression as occurs during clinical
renal transplantation. The techniques of microelectrophoresis are suitable
for assessment of the cell's electrophoretic properties, but at their
present state of development are not suitable for separation of cells in
sufficient quantity for in vitro it in vivo testing.
It became clear from these studies that, since an abnormality in
cell populations did occur, it was of paramount importance to develop in
vitro test systems that could determine unique functions of different
lymphocyte subpopulations. May of the biologically important immunologic
reactions involving B as well as T cells are mediated by cell-cell inter-
actions. One of the immediate problems that we recognized was the lack of
a suitable system ofr analyzing cell-cell interactions and the role
lymphocyte subpopulations might have in these interactions.
Therefore, we propose to continue this research by developing a model
system for the study of lymphocyte activation via cell-cell interactions.
r
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Previous studies in our laboratories have shown that agents that
generate aldehyde groups on the surface of lymphocytes lead to extensive
blastogenesis. Studies utilizing this system indicate that the induction
of blastogenesis by sodium periodate or galactose oxidase treatment of
the cells, treatments that lead to the generation of aldehyde groups
on the cell surface, require several lymphocyte subpopulations, and
involve different types of cell-cell interactions. Aldehyde-modified cells
can stimulate unmodified cells, provided that a third cell subpopulation,
i.e., macrophages, are present in the lymphocyte culture. In addition,
aldehyde-modified cells themselves may proliferate, provided again that
macrophages are present.
Thus, this system is composed of three interacting cellular elements:
[1] the stimulatorycell--that is, the aldehyde-modified cell (S); [2] the
responding cell (R); and [3] the helper cell, or macrophage (H).
We propose the following studies to define and characterize this model-
system for the study of lymphocyte activation induced by cell-cell inter-
action:
1. General Characterization of the System
(a) Assessment of the quantitative requirement for each cell
type (S, R, and H cells).
(b) The effect of various doses of the aldehyde-generating
agents (periodate or galactose oxidase) on the function
of S and R cells.
(c) A determination of the time course of the blastogenic
response in the system under various experimental con-
ditions, especially when the stimulatory cell or the
responding cell is modified.
2. Nature of the Cells That Compose This Triple-Cell Model Svstem
(a) The Nature of R Cells.	 Previous studies have shown that
the responsing cell in this experimental system is a T cell. However,
it is known that the T cell subpopulation is heterogeneous, and this
was also found in our studies on electrophoretic mobility of lympho-
cytes. These studies demonstrate a polydispersity of the T cell sub-
population. As an extension of the studies on the electrophoretic
mobility of T cells, we have now developed methods for quantitative sep-
aration of two of these T cell subgroups (Tyand Tu). This separation
is based on the nature of their surface receptor for the Pc portion of
either IgG or IgM.
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(b) The Nature of S Cells.
	 Previous studies have indicate
that aldehyde modification of unfractionated human peripheral lympho-
cytes render them capable of functioning as stimulatory cells. However,
the ability of purified T subgroups to function as S cells following
aldehyde modification should be evaluated. In addition, it would be of
the utmost interest to study the role of B cells as S cells in this system.
In this connection it would be of particular interest to study the properties
of B cells from transplant recipients, since a marked abnormality in
slectrophoretic mobility was found in this group of cells.
(c) The Nature of H Cells. Previous data indicate that cells that
adhere to glass or plastic surfaces can function as helper cells in this
system. Macrophages or monocytes can function both as helper and stimulatory
cells. The function of B cells and adherent T cell subpopulations as helper
cells must also be investigated. It would also be of interest to determine
the function of non-lymphoid cells as helper cells in this system, i.e.,
fibroblasts, endothelial cells, or other human cell types.
3. Nature of the Stimulatory Site Generated by Periodate and Galactose
Oxidase
This system provides a means to study the chemical nature of a
site that is involved in activating 7,yymphocytes via cell-cell interactions.
We will examine the two possible ways by which this site could be generated.
The stie may be identical to the aldehyde group generated on the cell surface,
or it may be related to other membrane sites that are generated as a
consequence of the surface alteration by the aldehyde-generating reagents.
This problem will be approached by the use of reagents known to react with
specific sties on the cell surface, such as aldehyde-blocking agents and
imuunoglobulins directed against products of the major histocompatibility
locus. In addition, we plan to analyze membrane components (as revealed by
polyacrylamide gel electrophoresis) of cells that are capable of functioning
as S cells. The metabolic requirements for the generation of the stimulatory
site will also be investigated.
Finally, since the reactions discussed above depend on cell-cell inter-
actions, they may be profoundly affected by 0 gravity conditions. This system
might, then, provide a unique experimental model to study the effects of 0
gravity on some aspects of the immune response, especially those intimately
associated with cell-cell interactions.
